BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17308243)

  • 1. Posttraumatic stress disorder-like symptoms after treatment with acetylcholinesterase inhibitors.
    McLay RN; Ho J
    J Neuropsychiatry Clin Neurosci; 2007; 19(1):92-3. PubMed ID: 17308243
    [No Abstract]   [Full Text] [Related]  

  • 2. An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients.
    Whyte EM; Lenze EJ; Butters M; Skidmore E; Koenig K; Dew MA; Penrod L; Mulsant BH; Pollock BG; Cabacungan L; Reynolds CF; Munin MC
    Cerebrovasc Dis; 2008; 26(3):317-21. PubMed ID: 18667813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: Post-traumatic memories triggered by donepezil in a dose-dependent pattern.
    Wolff ML
    Am J Geriatr Pharmacother; 2012 Jun; 10(3):219-22. PubMed ID: 22445625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Alzheimer drugs: life-threatening adverse effects.
    Prescrire Int; 2007 Feb; 16(87):16. PubMed ID: 17326275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galantamine: excess mortality.
    Prescrire Int; 2005 Jun; 14(77):103. PubMed ID: 15986514
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
    Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
    Harry RD; Zakzanis KK
    Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs for cognitive loss and dementia.
    Treat Guidel Med Lett; 2013 Oct; 11(134):95-100; quiz 1 p following p100.. PubMed ID: 24081314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview].
    Voss B; Thienel R; Leucht S; Kircher T
    Nervenarzt; 2008 Jan; 79(1):47-8, 50-2, 54-9. PubMed ID: 17960354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acetylcholinesterase inhibitor. Helpful not just in Alzheimer dementia].
    MMW Fortschr Med; 2002 Aug; 144(33-34):59. PubMed ID: 12380156
    [No Abstract]   [Full Text] [Related]  

  • 11. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
    Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease.
    Prescrire Int; 2003 Dec; 12(68):230-1. PubMed ID: 14986699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of donepezil on cognitive functioning in Down syndrome.
    Johnson N; Fahey C; Chicoine B; Chong G; Gitelman D
    Am J Ment Retard; 2003 Nov; 108(6):367-72. PubMed ID: 14561111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinesterase inhibitor treatment and urinary incontinence in Alzheimer's disease.
    Starr JM
    J Am Geriatr Soc; 2007 May; 55(5):800-1. PubMed ID: 17493206
    [No Abstract]   [Full Text] [Related]  

  • 15. Behavioral complications associated with donepezil.
    Wengel SP; Roccaforte WH; Burke WJ; Bayer BL; McNeilly DP; Knop D
    Am J Psychiatry; 1998 Nov; 155(11):1632-3. PubMed ID: 9812142
    [No Abstract]   [Full Text] [Related]  

  • 16. Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account.
    Prescrire Int; 2011 Apr; 20(115):95. PubMed ID: 21648211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
    Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M
    J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acetylcholinesterase inhibitors for treatment of cognitive and behavioral symptoms in dementia with Lewy bodies.
    Simard M; van Reekum R
    J Neuropsychiatry Clin Neurosci; 2004; 16(4):409-25. PubMed ID: 15616167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Featured CME topic: dementia. Medication update.
    Slagle MA
    South Med J; 2001 Jul; 94(7):678-81. PubMed ID: 11531174
    [No Abstract]   [Full Text] [Related]  

  • 20. Which cholinesterase inhibitor is the safest for the heart in elderly patients with Alzheimer's disease?
    Isik AT; Bozoglu E; Yay A; Soysal P; Ateskan U
    Am J Alzheimers Dis Other Demen; 2012 May; 27(3):171-4. PubMed ID: 22573283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.